Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2749074

Cl[Pt]Cl.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL7618853 1.00
Ammonia Solution, Strong SCHEMBL6043 1.00
Ammonia Solution, Strong SCHEMBL18606030 0.91
Ammonia Solution, Strong SCHEMBL2168836 0.91
SCHEMBL22689 0.89
Water SCHEMBL25354626 0.80
Water SCHEMBL28489054 0.80
Phosphine SCHEMBL5852309 0.80
SCHEMBL29195976 0.80
Water SCHEMBL3800295 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118925756-A Universal method for preparing self-supporting structure multi-element platinum ruthenium-based nanotube catalyst 安徽氢宇新能源科技有限公司 2024-11-12 CN claimed
US-8178462-B2 Method for production of electrode catalyst for fuel cell SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-05-15 US claimed
CN-1522178-A High surface area, small crystallite size catalyst for fischer-tropsch synthesis �յ�-��ѧ��˾ 2004-08-18 CN claimed
US-11964000-B2 Cancer treatment methods using nanofiber stabilized growth factors NORTHWESTERN UNIVERSITY (US) 2024-04-23 US disclosed
WO-2024040135-A2 METHODS OF ADMINISTERING NATURAL KILLER CELLS COMPRISING AN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) CHIMERIC ANTIGEN RECEPTOR (CAR) ARTIVA BIOTHERAPEUTICS, INC. (US) 2024-02-22 WO disclosed
EP-4319770-A1 TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY Artiva Biotherapeutics, Inc. (US) 2024-02-14 EP disclosed
EP-4319772-A1 TREATMENT OF CANCER WITH NK CELLS AND AN EGFR TARGETED ANTIBODY Artiva Biotherapeutics, Inc. (US) 2024-02-14 EP disclosed
EP-4319771-A1 TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY Artiva Biotherapeutics, Inc. (US) 2024-02-14 EP disclosed
EP-4319794-A2 CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME Artiva Biotherapeutics, Inc. (US) 2024-02-14 EP disclosed
EP-4319769-A1 TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY Artiva Biotherapeutics, Inc. (US) 2024-02-14 EP disclosed
EP-4319768-A1 CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME Artiva Biotherapeutics, Inc. (US) 2024-02-14 EP disclosed
EP-0036703-B1 PREPARATION OF METAL CONTAINING CATALYSTS MOBIL OIL CORPORATION (US) 1987-01-07 EP disclosed
US-4493764-A MIXTURE OF PLATINUM OR RHENIUM WITH IRIDIUM OR RHENIUM MOBIL OIL CORPORATION (US) 1985-01-15 US disclosed
US-4477590-A PLATINUM AND RHENIUM, AND IRIDIUM AND RHENIUM MOBIL OIL CORPORATION (US) 1984-10-16 US disclosed
EP-0103449-A1 Single particle multi-metallic reforming catalyst and process of using same MOBIL OIL CORPORATION (US) 1984-03-21 EP disclosed
EP-0036703-A2 Preparation of metal containing catalysts MOBIL OIL CORPORATION (US) 1981-09-30 EP disclosed
US-4079121-A USEFUL IN CANCER RESEARCH MOBIL OIL CORPORATION (US) 1978-03-14 US disclosed
US-4075307-A PREPARING A COMPLEX MOBIL OIL CORPORATION (US) 1978-02-21 US disclosed
US-3968225-A Preparation of spheroidal alumina particles LABOFINA S.A. (BE) 1976-07-06 US disclosed
US-3966996-A ADDITION POLYMERIZATION, DISPERSION LABOFINA S.A. (BE) 1976-06-29 US disclosed